New vaccine study aims to shield toddlers from deadly meningitis
NCT ID NCT05935176
First seen Mar 09, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study tests a vaccine that protects against four types of meningococcal bacteria that cause meningitis, a serious brain infection. It involves 660 children aged 6 to 23 months who receive two doses of the vaccine. Researchers check how well the vaccine triggers the immune system and how long protection lasts, with some children getting a booster shot at age 3.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDEMIC MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wuzhi County Center for Disease Control and Prevention
Jiaozuo, Henan, China
Conditions
Explore the condition pages connected to this study.